Northern Trust Company of Connecticut’s Charles River Laboratories CRL Stock Holding History

Northern Trust Company of Connecticut's CRL Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Charles River Laboratories (CRL) stake by 603% in Q4 2013, buying an estimated $351K and bringing the position to 8,151 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

Northern Trust Company of Connecticut first reported a position in CRL in Q2 2013 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold CRL as of Q4 2013.

• Northern Trust Company of Connecticut held 8,151 shares of Charles River Laboratories worth $432K as of Q4 2013.
• Northern Trust Company of Connecticut bought 6,991 Charles River Laboratories shares in Q4 2013, an estimated $351K.
• Charles River Laboratories made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1601 holding.
• Northern Trust Company of Connecticut first reported a position in Charles River Laboratories in Q2 2013 and has held it in 3 quarters since.
• 239 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.